EVOGENE LTD. Sales And Marketing Expense
EVOGENE LTD. (EVGN) reported Sales And Marketing Expense of $1.48 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2026-03-26
| Period end | Sales And Marketing Expense 6 month | Sales And Marketing Expense 6 month as first filed | Sales And Marketing Expense 12 month | Sales And Marketing Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $1.48M 20-F · filed 2026-03-26 | |||
| 2025-06-30 | $809.00K 6-K · filed 2025-09-30 | |||
| 2024-12-31 | $1.98M 20-F · filed 2026-03-26 | $3.42M 20-F · filed 2025-03-27 | ||
| 2024-06-30 | $1.11M 6-K · filed 2025-09-30 | $1.92M 6-K · filed 2024-09-16 | ||
| 2023-12-31 | $2.15M 20-F · filed 2026-03-26 | $3.61M 20-F · filed 2024-03-28 | ||
| 2023-06-30 | $1.73M 6-K · filed 2024-09-16 | |||
| 2022-12-31 | $3.93M 20-F · filed 2025-03-27 | |||
| 2022-06-30 | $1.87M 6-K · filed 2023-09-13 | |||
| 2021-12-31 | $2.74M 20-F · filed 2024-03-28 | |||
| 2020-12-31 | $2.67M 20-F · filed 2023-03-30 |